Amplification of fluorescent in situ hybridisation signals in formalin fixed paraffin wax embedded sections of colon tumour using biotinylated tyramide

被引:21
作者
McKay, JA [1 ]
Murray, GI
Keith, WN
McLeod, HL
机构
[1] Univ Aberdeen, Inst Med Sci, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland
[2] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland
[3] Univ Glasgow, Dept Med Oncol, CRC, Glasgow G61 1BD, Lanark, Scotland
来源
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY | 1997年 / 50卷 / 06期
关键词
fluorescent in situ hybridisation; amplification; biotinylated tyramide;
D O I
10.1136/mp.50.6.322
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Fluorescent in situ hybridisation (FISH) is a powerful tool for the evaluation of chromosomal alterations in formalin fixed paraffin wax embedded sections of colorectal cancer. However, initial experiments using a two-step detection system for digoxigenin labelled chromosome specific centromeric probes resulted in a complete lack of hybridisation signal from a number of colorectal tumour sections. This was due to high levels of background autofluorescence observed in this tissue, which masked any relatively weak hybridisations present. To overcome this problem, a biotinylated tyramide mediated amplification system was incorporated into the FISH detection protocol. This involves the use of horseradish peroxidase to activate the biotinylated tyramide, resulting in the deposition of a large number of biotin molecules at the site of bound peroxidase, which corresponds directly to the location of hybridised probe. Final detection was by means of a streptavidin-FITC conjugate. Using this technique, a panel of 11 colorectal tumour samples studied to date have shown strong, specific hybridisation signals to the nucleus of tumour cells. Amplification of FISH signals by biotinylated tyramide has the potential to improve weak hybridisation signals in cells from numerous sources, using a variety of probe types, including single copy gene probes as well as centromere specific probes.
引用
收藏
页码:322 / 325
页数:4
相关论文
共 15 条
[1]   CFOS IMMUNOREACTIVITY IS ENHANCED WITH BIOTIN AMPLIFICATION [J].
BERGHORN, KA ;
BONNETT, JH ;
HOFFMAN, GE .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1994, 42 (12) :1635-1642
[2]   CATALYZED REPORTER DEPOSITION, A NOVEL METHOD OF SIGNAL AMPLIFICATION .2. APPLICATION TO MEMBRANE IMMUNOASSAYS [J].
BOBROW, MN ;
SHAUGHNESSY, KJ ;
LITT, GJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 137 (01) :103-112
[3]   THE USE OF CATALYZED REPORTER DEPOSITION AS A MEANS OF SIGNAL AMPLIFICATION IN A VARIETY OF FORMATS [J].
BOBROW, MN ;
LITT, GJ ;
SHAUGHNESSY, KJ ;
MAYER, PC ;
CONLON, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 150 (1-2) :145-149
[4]   CATALYZED REPORTER DEPOSITION, A NOVEL METHOD OF SIGNAL AMPLIFICATION - APPLICATION TO IMMUNOASSAYS [J].
BOBROW, MN ;
HARRIS, TD ;
SHAUGHNESSY, KJ ;
LITT, GJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 125 (1-2) :279-285
[5]  
HOPMAN AHN, 1992, DIAGNOSTIC MOL PATHO, P141
[6]   LOSS OF HETEROZYGOSITY OF TUMOR-SUPPRESSOR GENE LOCI IN HUMAN COLORECTAL-CARCINOMA [J].
IACOPETTA, B ;
DIGRANDI, S ;
DIX, B ;
HAIG, C ;
SOONG, R ;
HOUSE, A .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (05) :664-670
[7]   ALLELIC LOSS OF CHROMOSOME 18Q AND PROGNOSIS IN COLORECTAL-CANCER [J].
JEN, J ;
KIM, HG ;
PIANTADOSI, S ;
LIU, ZF ;
LEVITT, RC ;
SISTONEN, P ;
KINZLER, KW ;
VOGELSTEIN, B ;
HAMILTON, SR .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (04) :213-221
[8]   A NOVEL IN-SITU HYBRIDIZATION SIGNAL AMPLIFICATION METHOD BASED ON THE DEPOSITION OF BIOTINYLATED TYRAMINE [J].
KERSTENS, HMJ ;
PODDIGHE, PJ ;
HANSELAAR, AGJM .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1995, 43 (04) :347-352
[9]  
LARSSON LI, 1989, IMMUNOCYTOCHEMISTRY
[10]   INTERPHASE CYTOGENETIC ANALYSIS OF ERBB2 AND TOPOII-ALPHA COAMPLIFICATION IN INVASIVE BREAST-CANCER AND POLYSOMY OF CHROMOSOME-17 IN DUCTAL CARCINOMA IN-SITU [J].
MURPHY, DS ;
MCHARDY, P ;
COUTTS, J ;
MALLON, EA ;
GEORGE, WD ;
KAYE, SB ;
BROWN, R ;
KEITH, WN .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (01) :18-26